This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe
November 3–5, 2025
Vienna Congress and Convention Center, Vienna, AustriaNovember 11–12, 2025 | Digital Partnering

Sunwoo Kim
Head of Business Development at Neuracle Genetics
Speaker

Profile

Sunwoo Kim is a seasoned investment and business development professional with over 16 years of experience in the biopharmaceutical industry. In 2023, he took on the role of Head of Business Development at Neuracle Genetics, where he is responsible for establishing and maintaining relationships with key stakeholders, including potential partners and investors, to identify and engage in business development opportunities. Sunwoo is also a Partner and Healthcare Portfolio Manager at QUAD Investment Management, where he has demonstrated his expertise in sourcing and investing in private and public biopharmaceutical companies across different therapeutic areas and modalities. Additionally, he oversees QUAD Capital Management US, based in New York. Sunwoo holds a Master of Biotechnology Enterprise and Entrepreneurship in Legal and Regulatory from Johns Hopkins University.